The global Association of Contract Research Organizations has issued two new documents outlining industry best practices on decentralized clinical trials (DCTs), which have assumed a new level of importance in light of the COVID-19 pandemic.
ACRO hopes that the documents developed by its DCT working party – a quality-by-design manual and a complementary risk assessment...








